Acne

Shanna Miranti, MMS, PA-C, reviews 2 patient cases of pseudo acne fulminans, offering perspectives on treatment and management strategies.

Acne vulgaris has been reported as an adverse effect of GLP-1 receptor agonists by some patients.

Over 6 weeks, most saw patients saw improvement, with daily medication linked to better quality of life and reduced skin picking.

At the correct dosage, researchers noted non-significant changes in BMI or metabolic syndrome markers among patients.

Although EBDs provided improvements over controls, they did not match the sebum reduction levels achieved by isotretinoin or hormonal therapies.

A recent study revealed that CO2 fractional laser was significantly more effective than microneedling for acne treatment with ALA-PDT.

While FDA action is awaited, dermatology clinicians can suggest BPO-free alternatives such as retinoids, salicylic acid, and more.

Patients with acne also had higher rates of abnormal zinc and vitamin D levels, especially in severe cases.

Investigators looked into pollutant-induced disruption of the skin barrier, increased transepidermal water loss, and heightened inflammatory responses.

The lotion effectively rebalanced the microbiota, reduced erythema and desquamation, and improved acne severity.

Social media misinformation related to acne vulgaris may require clinician intervention when discussing treatment with patients.

A recent study found that pharmacy professionals had an increased level of capability, opportunity, and motivation after accessing the resource.

Adhering to a Mediterranean diet and incorporating omega-3 supplements led to noticeable improvements in acne severity, reducing both inflammatory and non-inflammatory lesions in patients.

Andrea Zaenglein, MD, discussed the role of patient counseling and addressing "hormone phobia" in young patients treated with hormonal therapies for acne in her SPD 2024 session.

Some patients may be looking for alternatives to BPO, questioning its safety.

With the latest advancements in dermatology, there is a great range of treatments available to address the various types of acne scarring.

Researchers found that the hemp derivative addressed multiple facets of acne pathophysiology and improved acne scarring overall.

A retrospective review found that sarecycline, a narrow-spectrum tetracycline, may be beneficial for patients with POD.

Patients with acne scarring who received concurrent therapy with isotretinoin and fractional radiofrequency achieved significant reductions in acne scar volume.

Hilary Baldwin, MD, presents a case study of a 17-year-old high school student with moderate acne vulgaris on her face and back, which caused significant emotional distress and lowered self-esteem, and discusses the patient's treatment journey and the resolution achieved.

Hilary Baldwin, MD, a dermatologist, presents a case study of a 12-year-old overweight male patient with a two-year history of moderate facial acne, discussing her diagnostic process and recommended treatment plan.

Although acne is common for most people to experience in their lifetime, it is important to individualize treatment and provide appropriate care when working with a diverse patient base.

Continuing the discussion on the case of a 17-year-old patient with moderate acne, Heather Woolery-Lloyd, MD, FAAD, provides an overview of the utilization of clascoterone cream, highlighting the application process and its unique mechanism of action.

An expert dermatologist presents the case of a 17-year-old with moderate acne, and discusses the importance of the proper application layering of skin care and prescription products to optimize treatment efficacy.

Highlighting ways to maximize absorption of isotretinoin, Heather Woolery-Lloyd, MD, FAAD provides insights on dietary considerations and the role of micronized and food independent isotretinoin.